Atmus Filtration Technologies Inc. (ATMU) Spending and interest coverage
- R&D / revenue · 12 months: Value 2.04%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.75%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 2.04% | Research and development expense / revenue. Period ending 2026-06-30. $38.80M ÷ $1.90B × 100 ≈ 2.04% |
| Stock-based compensation / revenue · 12 months | 0.75% | Share-based compensation / revenue. Period ending 2026-06-30. $14.20M ÷ $1.90B × 100 ≈ 0.75% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 38.80M USD | Research and Development Expense |
| Revenue | 1.90B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 14.20M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 325.90M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $38.80M | $1.90B | $14.20M | $325.90M | (m) | 2.04% | 0.75% | (m) | (m) |
| 2026-03-31 | $39.70M | $1.83B | $13.50M | $310.40M | (m) | 2.17% | 0.74% | (m) | (m) |
| 2025-12-31 | $40.70M | $1.76B | $12.40M | $299.00M | (m) | 2.31% | 0.70% | (m) | (m) |
| 2025-09-30 | $40.20M | $1.72B | $11.10M | $283.10M | (m) | 2.33% | 0.64% | (m) | (m) |
| 2025-06-30 | $39.90M | $1.68B | $11.20M | $264.40M | (m) | 2.37% | 0.67% | (m) | (m) |
| 2025-03-31 | $39.60M | $1.66B | $12.20M | $262.50M | (m) | 2.39% | 0.74% | (m) | (m) |
| 2024-12-31 | $40.60M | $1.67B | $11.90M | $266.20M | (m) | 2.43% | 0.71% | (m) | (m) |
| 2024-09-30 | $39.50M | $1.66B | (m) | $267.80M | $42.00M | 2.38% | (m) | 6.38× | Reported |
| 2024-06-30 | $40.90M | $1.66B | (m) | $263.40M | $42.60M | 2.47% | (m) | 6.18× | Reported |
| 2024-03-31 | $42.80M | $1.64B | (m) | $247.80M | $36.30M | 2.62% | (m) | 6.83× | Reported |
| 2023-12-31 | $42.50M | $1.63B | (m) | $248.40M | $25.80M | 2.61% | (m) | 9.63× | Reported |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $38.60M | $1.56B | (m) | $203.90M | $700.00K | 2.47% | (m) | 291.29× | Reported |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $42.00M | $1.44B | (m) | $213.50M | $800.00K | 2.92% | (m) | 266.88× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dorman Products, Inc. (DORM) | United States | $3.641B | 18.26 |
| Versigent PLC (VGNT) | $3.205B | ||
| DANA Inc (DAN) | United States | $2.944B | 2.63 |
| GENTEX CORP (GNTX) | United States | $4.643B | 13.22 |
| Garrett Motion Inc. (GTX) | $4.732B | 9.95 | |
| VISTEON CORP (VC) | United States | $2.398B | 16.55 |
| PHINIA INC. (PHIN) | United States | $2.197B | 22.60 |
| PATRICK INDUSTRIES INC (PATK) | United States | $2.176B | 20.75 |
| LCI INDUSTRIES (LCII) | United States | $2.034B | 12.21 |
| LEAR CORP (LEA) | United States | $5.831B | 11.79 |